Trial NCT01339910

View at ClinicalTrials.gov 
Org. Study IDs: BMTCTN0901
Secondary IDs: 5U24CA076518 BMT CTN 0901 U01HL069294 U01HL069294-05

Last trial update was posted on 2023-01-04

MeSH Interventions

Busulfan Cyclophosphamide Fludarabine Fludarabine phosphate Melphalan Vidarabine

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Myelodysplastic Syndromes Preleukemia

Other Conditions

Leukemia, Myelocytic, Acute

Stopping Reasons

Accrual terminated as recommended by the data and safety monitoring board.

Limitations And Caveats

N/A

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID